EN
HI
Summary
As of 6 Oct, 2026, Zydus Lifesciences stock price is ₹1159.5. During the trading session, the stock has moved between an intraday low of ₹1145.00 and an intraday high of ₹1164.80. Over the last 52 weeks, Zydus Lifesciences has traded between ₹835.50 and ₹1232.10.
The stock has recorded a trading volume of 15,75,419 shares,. Its Average Traded Price (ATP) is ₹1155.12, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹1159.50.
Zydus Lifesciences has an upper circuit limit of ₹1252.90 and a lower circuit limit of ₹1025.10. The total value traded stands at ₹181.98 CR, and the delivery percentage for the day is 49.23%.
The stock is currently traded with a market lot size of 1. Zydus Lifesciences also offers a dividend yield of 0.09%.
Zydus Lifesciences Share Price Chart
Zydus Lifesciences Share Key Metrics
Volume
15.75 L
Market Cap
115660.57 CR
LTQ@LTP
1@1159.50
ATP
1155.12
Var Margin
13.24 %
Circuit Range
1025.1-1252.9
Delivery %
49.23 %
Value
181.98 CR
ASM/GSM
No
Market Lot
1
Zydus Lifesciences Fundamentals
P/E Ratio
25.16
P/B Ratio
4.21
Div. Yield
0.09
Sector P/E
42.19
Sector P/B
3.53
Sec. Div. Yield
0.52
Zydus Lifesciences Resistance and Support
Pivot 1139.37
Resistance
First Resistance
1150.64
Second Resistance
1162.27
Third Resistance
1173.54
Support
First Support
1127.74
Second Support
1116.47
Third Support
1104.84
Zydus Lifesciences Futures & Options
Zydus Lifesciences Option Chain
View Price, OI, Greeks & More...
27OCT26
1169.00
25.80 (2.26%)
23NOV26
1173.50
23.90 (2.08%)
29DEC26
1173.10
26.60 (2.32%)
ZYDUSLIFE|27OCT26 CE 1150.00
39.95
11.5 (40.42%)
ZYDUSLIFE|27OCT26 PE 1160.00
26.6
-15.2 (-36.36%)
Zydus Lifesciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Oct 06 2026 | 1145 | 1159.5 | 1.80% | 1164.8 | 1145 |
| Mon Oct 05 2026 | 1145.69 | 1139 | -0.58% | 1151 | 1128.09 |
| Thu Oct 01 2026 | 1151 | 1145.69 | -1.40% | 1158 | 1123.69 |
Zydus Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-11 | Quarterly Results |
| 2026-05-19 | Audited Results |
| 2026-02-09 | Quarterly Results |
| 2025-11-06 | Quarterly Results & Fund raising |
| 2025-08-12 | Quarterly Results |
| 2025-05-20 | Audited Results & Final Dividend |
| 2025-02-05 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
Zydus Lifesciences News
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus Life Science, in partnership with MSN, has launched the first generic version of Adempas in the US. The drug targets rare and progressive pulmonary hypertension conditions. Adempas recorded global sales of approximately USD 850 million in 2025.
Oct 05 2026 20:44:49
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Updates on Joint Venture
Zydus Life Science announced an extension of the closing date for its 50:50 joint venture with Sunshine Healthcare Lanka. The delay is due to pending condition precedents, with completion now expected by December 2026.
Oct 01 2026 21:35:11
Read More
Zydus Lifesciences Management
| Name | Position |
|---|---|
| Dhaval N Soni | Company Secretary & Compliance Officer |
| Pankaj R Patel | Chairman |
Zydus Lifesciences Similar Stocks
Sun Pharmaceutical Industries Ltd.
1804.10
24.40 (1.37%)
Divi's Laboratories Ltd.
9550.00
354.00 (3.85%)
Torrent Pharmaceuticals Ltd.
4772.00
0.00 (0.00%)
Lenskart Solutions Ltd.
684.85
-7.90 (1.14%)
Apollo Hospitals Enterprise Ltd.
7914.50
-70.50 (0.88%)
Cipla Ltd.
1340.20
4.70 (0.35%)
Laurus Labs Ltd.
2050.00
78.60 (3.99%)
Mankind Pharma Ltd.
2500.00
21.00 (0.85%)
Dr. Reddy's Laboratories Ltd.
1208.00
5.00 (0.42%)
Aurobindo Pharma Ltd.
1692.80
17.90 (1.07%)
Zydus Lifesciences FAQs
The Buying Price of Zydus Lifesciences share is 1159.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Zydus Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Zydus Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Zydus Lifesciences shares is 25.16. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Zydus Lifesciences shares is 4.21. Useful to assess the stock's value relative to its book value.
To assess Zydus Lifesciences’s valuation compare Sector P/E, P/B which are 42.19 & 3.53 with sector averages, along with growth rates and financial metrics.
The Market Cap of Zydus Lifesciences is 115660.57 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Zydus Lifesciences share price is 1232.10 & 835.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Zydus Lifesciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ZYDUSLIFE
